Lidocaine Market Size & Share, by Formulation (Injections, Creams, Ointments, Patches, Gels, Aerosol Liquids); Application (Dentistry, Cardiac Arrhythmia, Epilepsy, Cosmetics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3577
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Lidocaine Market size was over USD 904.2 million in 2023 and is projected to exceed USD 1.76 billion by 2036, witnessing over 5.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of lidocaine is assessed at USD 942.54 million. The growth of the market can be attributed to the increase in the number of surgeries, and escalating demand for lidocaine formulations around the world. Along with these, surge in the prevalence of periodontal diseases, such as gingivitis and periodontitis, is expected to augment the sales of the product globally in the forthcoming years. According to the World Health Organization, as of 2020, oral diseases affect nearly 3.5 billion people worldwide. In addition, it is calculated that 2.3 billion people suffer from caries of permanent teeth. Rise in healthcare expenditure and growing population of the elderly across the globe are also crucial factors predicted to lead the expansion of market in the near future. Furthermore, massive investments in research and development in the pharmaceutical sector is projected to offer profitable opportunities to the market in the imminent time.


Lidocaine-Market-Size
Get more information on this report: Request Free Sample PDF

Lidocaine Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Number of Surgeries Worldwide
  • Surge in the Prevalence of Periodontal Diseases Globally

Challenges

  • Stringent Regulatory Framework Regarding Medical Approval in Several Countries

Lidocaine Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.3%

Base Year Market Size (2023)

USD 904.2 million

Forecast Year Market Size (2036)

USD 1.76 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
 
Get more information on this report: Request Free Sample PDF

Lidocaine Segmentation

The market is segmented by application into dentistry, cardiac arrhythmia, epilepsy, cosmetics, and others, out of which, the dentistry segment is anticipated to hold the largest share in the global lidocaine market. This can be accounted to the extensive use of lidocaine hydrochloride injectable in various surgical dental procedures. Apart from this, increasing occurrence of dental disorders, coupled with chronic and acute pain associated with dental procedures are also assessed to bode well for the growth of the market segment. Additionally, on the basis of formulation, the ointments segment is evaluated to occupy the largest share during the forecast period ascribing to the burgeoning usage of lidocaine ointments in cutaneous procedures such as laser surgeries and soft tissue augmentation, and also as cosmetic surgery products.

Our in-depth analysis of the global market includes the following segments

         By Formulation

  • Injections
  • Creams
  • Ointments
  • Patches
  • Gels
  • Aerosol Liquids
  • Others

          By Application

  • Dentistry
  • Cardiac Arrhythmia
  • Epilepsy
  • Cosmetics
  • Others
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Lidocaine Industry - Regional Synopsis

On the basis of geographical analysis, the global lidocaine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. Asia Pacific industry is poised to account for largest revenue share by 2036, on the back of spiraling number of dental and cosmetic procedures, along with plastic surgeries. In addition, rapid increase in the region’s geriatric population, rise in production of oral care products, and large patient pool are also assessed to drive the region’s market growth in the coming years. Another report by the WHO depicts that the proportion of people aged 60 or above was 9.8% in 2017, and is calculated to increase up to 13.7% and 20.3% by 2030 and by 2050, respectively. Moreover, the lidocaine market in North America is projected to acquire the largest share during the forecast period owing to the high demand for lidocaine formulations, and rising investments in the healthcare sector, especially in the United States. Apart from these, strong presence of major market players is also evaluated to fuel the progress of market in the region.

Research Nester
Lidocaine-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Lidocaine Landscape

    • Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hisamitsu Pharmaceutical Co., Inc.
    • Jiangsu Tianji Pharmaceutical Co. Ltd.
    • Teikoku Pharma USA, Inc.
    • Sorrento Therapeutics, Inc
    • Olympus Corporation
    • Endo Pharmaceutical Inc.
    • Fujifilm Holdings Corporation
    • Actavis Labs UT Inc.
    • Dun & Bradstreet, Inc.

In the News

  • August 2021- Scilex Holding Company, which is a subsidiary of Sorrento Therapeutics, Inc., announced that ZTlido, 1.8%, a lidocaine topical system, has been added to multiple formularies, including two national PBMs (Pharmacy Benefit Managers), a national health plan and two regional health plans.

  • May 2018- Teikoku Pharma USA Inc. entered into an exclusive license agreement with Link Health Group LTD for the development and distribution of TPU’s flagship product Lidoderm in China.

Author Credits:  Radhika Pawar


  • Report ID: 3577
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of lidocaine is assessed at USD 942.54 million.

Lidocaine Market size was over USD 904.2 million in 2023 and is projected to exceed USD 1.76 billion by 2036, witnessing over 5.3% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by increasing number of surgeries worldwide and surge in the prevalence of periodontal diseases globally.

Asia Pacific industry is poised to account for largest revenue share by 2036, on the back of spiraling number of dental and cosmetic procedures, along with plastic surgeries.

The major players in the market are Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Jiangsu Tianji Pharmaceutical Co. Ltd., Teikoku Pharma USA, Inc., Sorrento Therapeutics, Inc., and others.
Lidocaine Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample